Many of us rely on drugs imported from developing countries like India. But a new report reveals the toxic industry that produces them and the people who pay the price.
Much like the historical practice of using Mercury to treat syphilis, GlaxoSmithKline's diet drug Orlistat could be an effective solution for the present but a dangerous precedent for the future.
Fast-tracked pharmaceuticals are on the market for an average of almost two years without beginning required safety tests, and the FDA is letting it happen.
When drug companies dupe the IRS by shifting their profits to low-tax countries, the rest of us have to pay billions of dollars in unnecessary taxes to make up for the shortfall.
